Study Summary
This trial is testing a new way to look at sleep problems, by monitoring people's brain waves, heart rate, and body temperature. They will also look at how well people sleep with and without auditory stimulation.
- Experimental
- Placebo
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 12 Secondary · Reporting Duration: 2 weeks
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Auditory Stimulation
1 of 2
Sham
1 of 2
Experimental Treatment
Non-Treatment Group
110 Total Participants · 2 Treatment Groups
Primary Treatment: Auditory Stimulation · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 25 - 45 · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is the cut-off age for inclusion in this research project set at 80 years or younger?
"This clinical trial has established a limited age range for patient enrolment, with the minimum being 25 years old and the maximum being 45." - Anonymous Online Contributor
To what extent is this experiment being undertaken by individuals?
"Affirmative. According to the details on clinicaltrials.gov, this research endeavour is currently looking for volunteers. The posting of the trial was initially made on August 12th 2022 and it has been kept up-to-date since then with a final update being published on that same day. One medical centre needs to recruit 110 participants in total for this investigation." - Anonymous Online Contributor
What is the ultimate goal of this research endeavor?
"The primary purpose of this one-week trial is to assess the amplitude of post-stimulation slow oscillations. Other outcomes will measure changes in objective memory consolidation, night-to-night variability of sleep efficiency, and correctly timed sound stimulations expressed as a percentage." - Anonymous Online Contributor
Could I possibly qualify for participation in this trial?
"This clinical trial requires 110 individuals aged between 25 and 45 who currently receive placebos. Furthermore, participants must satisfy the following conditions: a PHQ-9 score below 10 coupled with no current diagnosis of bipolar disorder or psychosis confirmed by the M.I.N.I., Primary Care PTSD Screen (PC-PTSD) score lower than 3 plus a positive current diagnosis of major depressive disorder or persistent depressive disorder verified via the Patient Health Questionnaire (PHQ-9), as well as being free from any Sleep Disorders Symptoms Checklist-25 symptoms excluding insomnia in certain cases and displaying minimal SCI scores above 3 on all items." - Anonymous Online Contributor
Are there openings in this clinical experiment currently available?
"Affirmative. Per clinicaltrials.gov, this trial is searching for applicants - it was first posted on August 12th 2022 and most recently updated the same day. This study requires 110 participants to be enrolled at a single site." - Anonymous Online Contributor